HIV Flashcards
1
Q
E138A
A
the most common mutation to emerge in patients taking rilpivirine
2
Q
HIV 2 resistant inherently to:
A
NNRTI’s
3
Q
Q148
A
integrase inhibitor resistance (including dolutegravir)
E138A
the most common mutation to emerge in patients taking rilpivirine
HIV 2 resistant inherently to:
NNRTI’s
Q148
integrase inhibitor resistance (including dolutegravir)